Trials / Completed
CompletedNCT06223204
GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography
GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography - a Pilot Project
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The GLEAM study aims at assessing the potential of electrical impedance tomography (EIT) for noninvasive glucose measurement.
Detailed description
Within the GLEAM study, paired samples of EIT and blood glucose measurements will be collected in individuals with type 1 diabetes during standardized euglycemia, hypoglycemia and hyperglycemia. These samples will be used to assess the potential of EIT for noninvasive glucose measurement and/or dysglycemia detection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Controlled euglycemia, hypoglycemia and hyperglycemia | EIT measurements are collected in different glycemic states (euglycemia, hypoglycemia and hyperglycemia). Venous blood glucose is measured using a gold-standard glucose analyzer. |
Timeline
- Start date
- 2024-01-31
- Primary completion
- 2024-04-10
- Completion
- 2024-04-10
- First posted
- 2024-01-25
- Last updated
- 2024-05-02
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06223204. Inclusion in this directory is not an endorsement.